Radisens’ patent portfolio exceeds twenty granted patents

Cork – Jul 11, 2019 – Radisens announced today that their intellectual property (IP) portfolio has now expanded to include over twenty granted patents across multiple geographies. It comes as the European patent office recently granted a European patent on Radisens’ acceleration-primed valving system published as EP 2,928,607.

The Radisens IP portfolio comprises various patents granted to protect inventions focused on developing a novel point-of-care platform to rapidly monitor specific chronic diseases and micronutrients in biological samples. Such inventions include various methods to process biological samples and optically detect biological signatures within centrifugal microfluidic systems. Multiple other patents are pending.